Matches in SemOpenAlex for { <https://semopenalex.org/work/W4254920707> ?p ?o ?g. }
- W4254920707 abstract "Background Strength training or aerobic exercise programmes might optimise muscle and cardiorespiratory function and prevent additional disuse atrophy and deconditioning in people with a muscle disease. Objectives To examine the safety and efficacy of strength training and aerobic exercise training in people with a muscle disease. Search methods We searched the Cochrane Neuromuscular Disease Group Trials Specialized Register (July 2009), the Cochrane Rehabilitation and Related Therapies Field Register (October 2002, August 2008 and July 2009), The Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 3, 2009) MEDLINE (January 1966 to July 2009), EMBASE (January 1974 to July 2009), EMBASE Classic (1947 to 1973) and CINAHL (January 1982 to July 2009). Selection criteria Randomised or quasi‐randomised controlled trials comparing strength training or aerobic exercise programmes, or both, to no training, and lasting at least 10 weeks. For strength training Primary outcome: static or dynamic muscle strength. Secondary: muscle endurance or muscle fatigue, functional assessments, quality of life, muscle membrane permeability, pain and experienced fatigue. For aerobic exercise training Primary outcome: aerobic capacity expressed as work capacity. Secondary: aerobic capacity (oxygen consumption, parameters of cardiac or respiratory function), functional assessments, quality of life, muscle membrane permeability, pain and experienced fatigue. Data collection and analysis Two authors independently assessed trial quality and extracted the data. Main results We included three trials (121 participants). The first compared the effect of strength training versus no training in 36 people with myotonic dystrophy. The second trial compared strength training versus no training, both combined with albuterol or placebo, in 65 people with facioscapulohumeral muscular dystrophy. The third trial compared combined strength training and aerobic exercise versus no training in 18 people with mitochondrial myopathy. In the myotonic dystrophy trial there were no significant differences between training and non‐training groups for primary and secondary outcome measures. In the facioscapulohumeral muscular dystrophy trial only a +1.17 kg difference (95% confidence interval 0.18 to 2.16) in dynamic strength of elbow flexors in favour of the training group reached statistical significance. In the mitochondrial myopathy trial there were no significant differences in dynamic strength measures between training and non‐training groups. Exercise duration and distance cycled in a submaximal endurance test increased significantly in the training group compared to the control group. Authors' conclusions In myotonic dystrophy and facioscapulohumeral muscular dystrophy, moderate‐intensity strength training appears not to do harm but there is insufficient evidence to conclude that it offers benefit. In mitochondrial myopathy, aerobic exercise combined with strength training appears to be safe and may be effective in increasing submaximal endurance capacity. Limitations in the design of studies in other muscle diseases prevent more general conclusions in these disorders." @default.
- W4254920707 created "2022-05-12" @default.
- W4254920707 creator A5005421017 @default.
- W4254920707 creator A5008743688 @default.
- W4254920707 creator A5021550418 @default.
- W4254920707 creator A5038277642 @default.
- W4254920707 creator A5060863254 @default.
- W4254920707 creator A5087870639 @default.
- W4254920707 date "2010-01-20" @default.
- W4254920707 modified "2023-09-28" @default.
- W4254920707 title "Strength training and aerobic exercise training for muscle disease" @default.
- W4254920707 cites W1598602811 @default.
- W4254920707 cites W1967156261 @default.
- W4254920707 cites W1967225780 @default.
- W4254920707 cites W1967277020 @default.
- W4254920707 cites W1973306657 @default.
- W4254920707 cites W1974155532 @default.
- W4254920707 cites W1975368374 @default.
- W4254920707 cites W1977373711 @default.
- W4254920707 cites W1978718201 @default.
- W4254920707 cites W1981750006 @default.
- W4254920707 cites W1985764459 @default.
- W4254920707 cites W1996344495 @default.
- W4254920707 cites W2002950502 @default.
- W4254920707 cites W2010476133 @default.
- W4254920707 cites W2015705765 @default.
- W4254920707 cites W2018682987 @default.
- W4254920707 cites W2019566352 @default.
- W4254920707 cites W2023041963 @default.
- W4254920707 cites W2029113292 @default.
- W4254920707 cites W2033816963 @default.
- W4254920707 cites W2047675457 @default.
- W4254920707 cites W2048386082 @default.
- W4254920707 cites W2049637962 @default.
- W4254920707 cites W2050249279 @default.
- W4254920707 cites W2050704020 @default.
- W4254920707 cites W2056159604 @default.
- W4254920707 cites W2057029746 @default.
- W4254920707 cites W2057092244 @default.
- W4254920707 cites W2065335605 @default.
- W4254920707 cites W2069582574 @default.
- W4254920707 cites W2078218199 @default.
- W4254920707 cites W2095455036 @default.
- W4254920707 cites W2097076310 @default.
- W4254920707 cites W2097109814 @default.
- W4254920707 cites W2098925350 @default.
- W4254920707 cites W2099298220 @default.
- W4254920707 cites W2100597694 @default.
- W4254920707 cites W2102263767 @default.
- W4254920707 cites W2106047920 @default.
- W4254920707 cites W2106347908 @default.
- W4254920707 cites W2110675340 @default.
- W4254920707 cites W2111001861 @default.
- W4254920707 cites W2126462593 @default.
- W4254920707 cites W2130183664 @default.
- W4254920707 cites W2134857359 @default.
- W4254920707 cites W2139272776 @default.
- W4254920707 cites W2157374866 @default.
- W4254920707 cites W2158136973 @default.
- W4254920707 cites W2160113096 @default.
- W4254920707 cites W2161929859 @default.
- W4254920707 cites W2169878653 @default.
- W4254920707 cites W2248894983 @default.
- W4254920707 cites W2316282744 @default.
- W4254920707 cites W2335409751 @default.
- W4254920707 cites W2411989457 @default.
- W4254920707 cites W2413311099 @default.
- W4254920707 cites W4211030233 @default.
- W4254920707 cites W44709331 @default.
- W4254920707 doi "https://doi.org/10.1002/14651858.cd003907.pub3" @default.
- W4254920707 hasPublicationYear "2010" @default.
- W4254920707 type Work @default.
- W4254920707 citedByCount "19" @default.
- W4254920707 countsByYear W42549207072012 @default.
- W4254920707 countsByYear W42549207072013 @default.
- W4254920707 countsByYear W42549207072014 @default.
- W4254920707 countsByYear W42549207072016 @default.
- W4254920707 countsByYear W42549207072019 @default.
- W4254920707 countsByYear W42549207072020 @default.
- W4254920707 countsByYear W42549207072021 @default.
- W4254920707 countsByYear W42549207072022 @default.
- W4254920707 countsByYear W42549207072023 @default.
- W4254920707 crossrefType "reference-entry" @default.
- W4254920707 hasAuthorship W4254920707A5005421017 @default.
- W4254920707 hasAuthorship W4254920707A5008743688 @default.
- W4254920707 hasAuthorship W4254920707A5021550418 @default.
- W4254920707 hasAuthorship W4254920707A5038277642 @default.
- W4254920707 hasAuthorship W4254920707A5060863254 @default.
- W4254920707 hasAuthorship W4254920707A5087870639 @default.
- W4254920707 hasBestOaLocation W42549207072 @default.
- W4254920707 hasConcept C103038586 @default.
- W4254920707 hasConcept C117437137 @default.
- W4254920707 hasConcept C123550912 @default.
- W4254920707 hasConcept C126322002 @default.
- W4254920707 hasConcept C142724271 @default.
- W4254920707 hasConcept C168563851 @default.
- W4254920707 hasConcept C1862650 @default.
- W4254920707 hasConcept C196310339 @default.
- W4254920707 hasConcept C204787440 @default.
- W4254920707 hasConcept C27081682 @default.